This is a table of type trigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
trigram | frequency |
---|---|
as well as | 1014 |
the treatment of | 933 |
the use of | 739 |
in patients with | 721 |
for the treatment | 563 |
the development of | 554 |
in order to | 466 |
the presence of | 465 |
one of the | 463 |
the number of | 419 |
of the drug | 407 |
due to the | 397 |
based on the | 397 |
background and objective | 367 |
in the treatment | 327 |
it has been | 308 |
the role of | 290 |
main outcome measures | 278 |
can be used | 272 |
in addition to | 257 |
the effect of | 255 |
specify your abstract | 254 |
please specify your | 254 |
your abstract type | 254 |
or case report | 241 |
purpose or case | 241 |
the effects of | 238 |
severe acute respiratory | 235 |
the management of | 229 |
acute respiratory syndrome | 228 |
the risk of | 217 |
a number of | 216 |
of this study | 212 |
be used to | 210 |
an increase in | 209 |
a variety of | 208 |
treatment of covid | 204 |
there is a | 203 |
the aim of | 201 |
in vitro and | 200 |
for treatment of | 199 |
respiratory syndrome coronavirus | 199 |
in combination with | 198 |
according to the | 197 |
times a day | 196 |
of patients with | 195 |
and in vivo | 191 |
on the other | 189 |
in this study | 188 |
a total of | 187 |
the most common | 184 |
as a result | 183 |
used in the | 182 |
food and drug | 182 |
compared to the | 181 |
and drug administration | 179 |
the impact of | 179 |
found to be | 177 |
the other hand | 176 |
of the patients | 176 |
been shown to | 175 |
vitro and in | 175 |
such as the | 173 |
increase in the | 170 |
was used to | 166 |
that can be | 166 |
of the most | 165 |
setting and method | 165 |
in the presence | 163 |
has also been | 162 |
has been shown | 161 |
hepatitis c virus | 160 |
has been reported | 158 |
the efficacy of | 157 |
the case of | 156 |
part of the | 155 |
in terms of | 155 |
study was to | 155 |
well as the | 153 |
the absence of | 152 |
is associated with | 151 |
of the drugs | 151 |
abstract background and | 150 |
have also been | 150 |
research abstract background | 150 |
drug delivery systems | 149 |
the formation of | 149 |
there is no | 148 |
associated with the | 148 |
to evaluate the | 148 |
the need for | 147 |
mechanism of action | 146 |
have been reported | 146 |
most of the | 145 |
involved in the | 143 |
a result of | 143 |
some of the | 143 |
a review of | 139 |
role in the | 139 |
the discovery of | 138 |
in response to | 136 |
related to the | 135 |
of these drugs | 133 |
in the case | 132 |
the purpose of | 132 |
to be a | 132 |
to improve the | 131 |
was found to | 130 |
can also be | 130 |
be used for | 129 |
in the absence | 128 |
the results of | 127 |
drug delivery system | 126 |
with respect to | 126 |
of the disease | 125 |
the importance of | 124 |
patients with covid | 124 |
is one of | 124 |
to determine the | 124 |
have been used | 123 |
the united states | 122 |
p r e | 121 |
p r o | 121 |
n a l | 120 |
o o f | 120 |
r n a | 120 |
u r n | 120 |
structure of the | 120 |
o u r | 120 |
l p r | 120 |
is the most | 120 |
j o u | 120 |
this study was | 120 |
r o o | 120 |
a l p | 120 |
review of the | 119 |
the lack of | 119 |
need to be | 117 |
used for the | 116 |
to assess the | 116 |
it can be | 116 |
used to treat | 116 |
in the lungs | 116 |
because of the | 115 |
found in the | 115 |
analysis of the | 114 |
used as a | 113 |
aim of this | 113 |
chloroquine and hydroxychloroquine | 113 |
have shown that | 112 |
which can be | 112 |
the fact that | 112 |
world health organization | 111 |
the expression of | 110 |
it is important | 110 |
is important to | 110 |
to reduce the | 109 |
the activity of | 109 |
the potential to | 109 |
of the virus | 109 |
the majority of | 109 |
for drug delivery | 109 |
due to its | 108 |
the identification of | 108 |
the administration of | 107 |
a systematic review | 107 |
the process of | 106 |
to investigate the | 106 |
the field of | 106 |
in the united | 105 |
the effectiveness of | 105 |
toxic epidermal necrolysis | 105 |
the delivery of | 105 |
as compared to | 104 |
in drug discovery | 103 |
the level of | 103 |
and safety of | 102 |
in the development | 102 |
the incidence of | 102 |
in the rat | 101 |
twice a day | 100 |
has not been | 100 |
a combination of | 100 |
at least one | 100 |
understanding of the | 99 |
responsible for the | 99 |
of the human | 99 |
associated with a | 99 |
drug discovery and | 99 |
included in the | 98 |
e times a | 98 |
of action of | 98 |
wide range of | 97 |
efficacy and safety | 97 |
be used as | 97 |
the context of | 97 |
the influence of | 97 |
east respiratory syndrome | 97 |
been reported to | 96 |
in the field | 96 |
the mechanism of | 96 |
the basis of | 96 |
middle east respiratory | 95 |
evaluation of the | 95 |
an important role | 94 |
and in the | 94 |
human immunodeficiency virus | 94 |
the design of | 94 |
changes in the | 94 |
adverse drug reactions | 94 |
patients treated with | 93 |
of the study | 93 |
the application of | 93 |
due to their | 93 |
a range of | 93 |
in the context | 92 |
in case of | 92 |
the production of | 92 |
in the human | 92 |
important role in | 91 |
are associated with | 91 |
for the management | 91 |
can lead to | 91 |
the release of | 90 |
and treatment of | 90 |
has been used | 90 |
a wide range | 90 |
as a potential | 90 |
depending on the | 90 |
the quality of | 90 |
amino acid composition | 90 |
there was no | 89 |
antiviral activity of | 89 |
shown to be | 89 |
in contrast to | 89 |
to be the | 88 |
of a drug | 88 |
a series of | 88 |
the evaluation of | 88 |
is based on | 88 |
been used to | 87 |
in the lung | 87 |
and can be | 87 |
the amount of | 87 |
this study is | 87 |
the end of | 87 |
study is to | 87 |
the course of | 87 |
in clinical trials | 86 |
use of a | 86 |
the most important | 85 |
for patients with | 85 |
it is not | 85 |
once a day | 85 |
for the development | 84 |
in the first | 84 |
was carried out | 84 |
the combination of | 84 |
as part of | 84 |
the diagnosis of | 84 |
in the same | 84 |
purpose of this | 84 |
the ability to | 84 |
were used to | 84 |
on the basis | 83 |
the surface of | 83 |
in the management | 83 |
diseases such as | 83 |
effects of the | 83 |
be associated with | 82 |
study of the | 82 |
at the same | 82 |
based on a | 82 |
the frequency of | 82 |
in the past | 82 |
the interaction of | 82 |
which is a | 82 |
it should be | 82 |
shown in figure | 81 |
of the sars | 81 |
addition to the | 81 |
of the lung | 80 |
in the liver | 80 |
were found to | 80 |
should be considered | 80 |
patients with severe | 80 |
inhibition of the | 80 |
appears to be | 80 |
the present study | 80 |
be used in | 80 |
the potential of | 79 |
may also be | 78 |
adsorption energy of | 78 |
to identify the | 78 |
it is a | 77 |
been reported in | 77 |
epidermal growth factor | 77 |
the inhibition of | 77 |
is necessary to | 76 |
to study the | 76 |
and in vitro | 76 |
in the study | 76 |
the drug is | 76 |
quality of life | 75 |
was associated with | 75 |
central nervous system | 75 |
for drug discovery | 75 |
the small intestine | 75 |
the binding of | 75 |
development of a | 75 |
in which the | 75 |
cells in the | 74 |
could be used | 74 |
the active site | 74 |
have been developed | 74 |
that have been | 74 |
it is also | 74 |
effect on the | 74 |
each of the | 74 |
in the literature | 74 |
discovery and development | 73 |
is an important | 73 |
drugs have been | 72 |
respiratory distress syndrome | 72 |
the prevalence of | 72 |
drugs such as | 72 |
with regard to | 72 |
in accordance with | 72 |
activity of the | 72 |
crystal structure of | 72 |
as shown in | 72 |
the main protease | 72 |
the possibility of | 71 |
of severe acute | 71 |
present in the | 71 |
use of the | 70 |
in the last | 70 |
the same time | 70 |
granted medrxiv a | 69 |
studies have shown | 69 |
approved by the | 69 |
the range of | 69 |
display the preprint | 69 |
needs to be | 69 |
who has granted | 69 |
to be effective | 69 |
the ability of | 69 |
to display the | 69 |
preprint in perpetuity | 69 |
large number of | 69 |
license to display | 69 |
a license to | 69 |
in the stomach | 69 |
pseudo amino acid | 69 |
the gastrointestinal tract | 69 |
the preprint in | 69 |
medrxiv a license | 69 |
has granted medrxiv | 69 |
and characterization of | 68 |
the pathogenesis of | 68 |
the in vitro | 68 |
drugs in the | 68 |
is used to | 68 |
targeted delivery of | 68 |
influenza a virus | 68 |
some of these | 67 |
the rate of | 67 |
a and b | 67 |
in a patient | 67 |
in cases of | 67 |
dependent rna polymerase | 67 |
guidelines for the | 67 |
to be used | 67 |
it is possible | 67 |
for the first | 67 |
and it is | 66 |
been associated with | 66 |
the objective of | 66 |
decrease in the | 66 |
that has been | 66 |
observed in the | 66 |
may lead to | 66 |
are the most | 66 |
contribute to the | 65 |
the onset of | 65 |
the study of | 65 |
a period of | 65 |
the degree of | 65 |
acute respiratory distress | 65 |
the severity of | 65 |
over the past | 65 |
the world health | 65 |
caused by the | 65 |
the structure of | 64 |
a decrease in | 64 |
combination therapy with | 64 |
the type of | 64 |
l energy gap | 64 |
the detection of | 64 |
the proportion of | 64 |
in the pediatric | 64 |
led to the | 64 |
likely to be | 63 |
is that the | 63 |
the synthesis of | 63 |
the addition of | 63 |
in the small | 63 |
there are no | 63 |
the novel coronavirus | 63 |
of novel coronavirus | 63 |
the time of | 63 |
should be selected | 63 |
well as in | 63 |
of the protein | 63 |
of drugs and | 63 |
the pharmaceutical industry | 62 |
the extent of | 62 |
a patient with | 62 |
targeted drug delivery | 62 |
in the us | 62 |
in comparison to | 62 |
of a new | 62 |
is a major | 62 |
the analysis of | 62 |
in the number | 62 |
half of the | 62 |
the duration of | 62 |
the copyright holder | 62 |
in the s | 62 |
a set of | 61 |
a role in | 61 |
can be found | 61 |
was observed in | 61 |
copyright holder for | 61 |
holder for this | 61 |
in this case | 61 |
adverse effects of | 61 |
out of the | 61 |
for this preprint | 61 |
in some cases | 61 |
are able to | 61 |
in recent years | 61 |
results of the | 60 |
in the future | 60 |
was used for | 60 |
increased risk of | 60 |
reported in the | 60 |
has to be | 60 |
size of the | 60 |
the pharmacokinetics of | 60 |
drugs should be | 60 |
mechanisms of action | 59 |
in the early | 59 |
of the total | 59 |
that there is | 59 |
the prevention of | 59 |
more than one | 59 |
the immune system | 59 |
properties of the | 59 |
an overview of | 59 |
in this review | 59 |
the size of | 59 |
objective of this | 59 |
showed that the | 59 |
of chloroquine and | 59 |
drugs to be | 59 |
morbidity and mortality | 59 |
total number of | 59 |
also be used | 58 |
intensive care unit | 58 |
aim of the | 58 |
effect of the | 58 |
g e times | 58 |
end of the | 58 |
along with the | 58 |
in relation to | 58 |
are needed to | 58 |
compared with the | 58 |
been used in | 58 |
may be a | 58 |
the activation of | 58 |
the relationship between | 58 |
that could be | 58 |
mode of action | 58 |
the study was | 58 |
on the surface | 58 |
growth factor receptor | 58 |
are shown in | 58 |
to treat covid | 58 |
for the delivery | 57 |
of the viral | 57 |
seems to be | 57 |
which may be | 57 |
the concept of | 57 |
may not be | 57 |
differences in the | 57 |
years of age | 57 |
many of the | 57 |
nature of the | 57 |
be able to | 57 |
of infectious diseases | 57 |
derived from the | 57 |
parts of the | 57 |
was shown to | 56 |
is responsible for | 56 |
to increase the | 56 |
different types of | 56 |
of cyp a | 56 |
inhibitors of the | 56 |
at the time | 56 |
which was not | 56 |
in cell culture | 56 |
critically ill patients | 56 |
the action of | 56 |
the concentration of | 56 |
mg twice a | 56 |
the assessment of | 56 |
in children with | 56 |
has been suggested | 56 |
leading to the | 56 |
it may be | 56 |
for use in | 56 |
in a study | 56 |
with the use | 56 |
assessment of the | 56 |
of hepatitis c | 55 |
were included in | 55 |
shown that the | 55 |
the most commonly | 55 |
of the clinical | 55 |
side effects of | 55 |
depends on the | 55 |
to understand the | 55 |
known to be | 55 |
by the fda | 55 |
at the end | 55 |
that of the | 55 |
to have a | 55 |
are used to | 55 |
the form of | 55 |
the need to | 55 |
more than of | 55 |
because of its | 55 |
is essential for | 54 |
also known as | 54 |
the performance of | 54 |
similar to the | 54 |
be found in | 54 |
cells of the | 54 |
to the development | 54 |
in the body | 54 |
we found that | 54 |
to develop a | 54 |
the drug and | 54 |
they can be | 54 |
of a novel | 54 |
in many cases | 54 |
a list of | 54 |
patients with a | 54 |
is known to | 54 |
the introduction of | 53 |
diagnosis and treatment | 53 |
may result in | 53 |
all rights reserved | 53 |
has been demonstrated | 53 |
drug repurposing for | 53 |
a large number | 53 |
when compared with | 53 |
in the blood | 53 |
binding free energy | 53 |
drug delivery and | 53 |
been used for | 53 |
stability of the | 53 |
been found to | 53 |
were treated with | 53 |
were able to | 52 |
safety and efficacy | 52 |
a lack of | 52 |
the cost of | 52 |
hepatitis b virus | 52 |
of the patient | 52 |
kg times a | 52 |
due to a | 52 |
as high as | 52 |
effects on the | 52 |
and development of | 52 |
patients with chronic | 52 |
to the drug | 52 |
there is an | 52 |
herpes simplex virus | 52 |
of the literature | 52 |
has the potential | 52 |
reported to be | 52 |
mg kg times | 52 |
it is necessary | 52 |
number of patients | 52 |
the result of | 52 |
the growth of | 51 |
breast cancer cells | 51 |
the leading edge | 51 |
role of the | 51 |
have to be | 51 |
magnetic resonance imaging | 51 |
in this context | 51 |
are responsible for | 51 |
there was a | 51 |
prevention and treatment | 51 |
in a recent | 51 |
surface of the | 51 |
are known to | 51 |
risk factors for | 51 |
resulted in a | 51 |
the stability of | 51 |
fda approved drugs | 51 |
widely used in | 51 |
in the form | 51 |
in drug delivery | 51 |
to enhance the | 51 |
was used as | 50 |
is defined as | 50 |
have been described | 50 |
is able to | 50 |
systematic review of | 50 |
development of the | 50 |
the most frequent | 50 |
in treatment of | 50 |
has been found | 50 |
when compared to | 50 |
the value of | 50 |
activation of the | 50 |
of drug resistance | 50 |
by means of | 50 |
this is a | 50 |
of the rat | 50 |
have been shown | 50 |
the efficacy and | 50 |
treatment of severe | 50 |
cell lung cancer | 50 |
the respiratory tract | 50 |
of the main | 50 |
reduction in the | 50 |
in the current | 49 |
to inhibit the | 49 |
solid lipid nanoparticles | 49 |
the potential for | 49 |
similar to those | 49 |
tumor necrosis factor | 49 |
should not be | 49 |
of the target | 49 |
of clinical trials | 49 |
this type of | 49 |
should be used | 49 |
been shown that | 49 |
there are many | 49 |
with severe covid | 49 |
function of the | 49 |
in the following | 48 |
lung cancer cells | 48 |
as a drug | 48 |
the induction of | 48 |
in association with | 48 |
efficacy of the | 48 |
with or without | 48 |
of the channel | 48 |
is characterized by | 48 |
before and after | 48 |
the adsorption of | 48 |
of cytochrome p | 48 |
of antimicrobial drugs | 48 |
of the cases | 48 |
been widely used | 48 |
information about the | 48 |
of the small | 48 |
characterization of the | 48 |
obtained from the | 47 |
are involved in | 47 |
pulmonary drug delivery | 47 |
there has been | 47 |
have the potential | 47 |
a study of | 47 |
lead to the | 47 |
a group of | 47 |
which has been | 47 |
of more than | 47 |
found that the | 47 |
in of the | 47 |
more likely to | 47 |
chronic hepatitis c | 47 |
dose of mg | 47 |
to examine the | 47 |
development of new | 47 |
the site of | 47 |
the total number | 47 |
led to a | 47 |
recent advances in | 47 |
a recent study | 47 |
appear to be | 47 |
an inhibitor of | 47 |
the host cell | 47 |
systemic lupus erythematosus | 47 |
have not been | 47 |
been suggested that | 47 |
the function of | 47 |
in laboratory animals | 47 |
the safety of | 47 |
of coronavirus disease | 46 |
of this drug | 46 |
as in the | 46 |
to provide a | 46 |
in vivo studies | 46 |
change in the | 46 |
there have been | 46 |
drugs for the | 46 |
their ability to | 46 |
the food and | 46 |
was able to | 46 |
by the presence | 46 |
clinical trials for | 46 |
an in vitro | 46 |
in drug design | 46 |
should be performed | 46 |
the emergence of | 46 |
will be discussed | 46 |
of influenza a | 46 |
of the treatment | 46 |
supported by the | 46 |
wide variety of | 46 |
the involvement of | 46 |
the selection of | 46 |
the regulation of | 45 |
treatment of patients | 45 |
response to the | 45 |
the replication of | 45 |
antiviral activity against | 45 |
described in the | 45 |
for the prevention | 45 |
is related to | 45 |
are required to | 45 |
impact of the | 45 |
to that of | 45 |
in the range | 45 |
study on the | 45 |
of the first | 45 |
a wide variety | 45 |
the nature of | 45 |
all of the | 45 |
as a consequence | 45 |
and efficacy of | 45 |
with an increase | 44 |
presence of a | 44 |
presence of the | 44 |
that it is | 44 |
have been identified | 44 |
the progression of | 44 |
and cyp a | 44 |
the distribution of | 44 |
based on their | 44 |
knowledge of the | 44 |
of all the | 44 |
lead to a | 44 |
referred to as | 44 |
because of their | 44 |
followed by a | 44 |
a history of | 44 |
use in the | 44 |
for drug repurposing | 44 |
or in combination | 44 |
a case report | 44 |
cancer stem cells | 44 |
in our hospital | 44 |
resulting in a | 44 |
there are several | 44 |
is caused by | 44 |
in a mouse | 44 |
impact on the | 44 |
the drug in | 44 |
the setting of | 44 |
prior to the | 44 |
of these patients | 44 |
head and neck | 44 |
it has also | 43 |
to be recommended | 43 |
shown in fig | 43 |
respiratory syncytial virus | 43 |
could not be | 43 |
the in vivo | 43 |
used to identify | 43 |
were used as | 43 |
the immune response | 43 |
has been proposed | 43 |
reactive oxygen species | 43 |
is the first | 43 |
delivery system for | 43 |
for breast cancer | 43 |
the success of | 43 |
also been used | 43 |
be combined with | 43 |
is also a | 43 |
can be achieved | 43 |
mg kg day | 43 |
of the ligand | 43 |
be related to | 43 |
is not a | 43 |
this can be | 43 |
chronic obstructive pulmonary | 42 |
the first time | 42 |
inflammatory bowel disease | 42 |
to be associated | 42 |
be due to | 42 |
based drug design | 42 |
the antiviral activity | 42 |
located in the | 42 |
is shown in | 42 |
members of the | 42 |
is likely to | 42 |
of the lungs | 42 |
are likely to | 42 |
and drug delivery | 42 |
an example of | 42 |
is difficult to | 42 |
have been proposed | 42 |
the human body | 42 |
should also be | 42 |
the appearance of | 42 |
a reduction in | 42 |
one or more | 42 |
administration of the | 42 |
in the setting | 42 |
the search for | 42 |
to predict the | 42 |
obstructive pulmonary disease | 42 |
of lung cancer | 42 |
in our study | 42 |
a mouse model | 42 |
leading edge pseudopod | 42 |
are found in | 42 |
in this regard | 42 |
the binding site | 42 |
provided by the | 42 |
the plasma membrane | 42 |
in vitro studies | 42 |
than in the | 41 |
be involved in | 41 |
to reach the | 41 |
member of the | 41 |
effects of chloroquine | 41 |
based drug discovery | 41 |
of drug delivery | 41 |
with and without | 41 |
to be an | 41 |
drugs for covid | 41 |
during the covid | 41 |
of the two | 41 |
of side effects | 41 |
in clinical practice | 41 |
high levels of | 41 |
conflict of interest | 41 |
information on the | 41 |
this is the | 41 |
in vivo and | 41 |
treatment of the | 41 |
treatment of sars | 41 |
oral delivery of | 41 |
results of a | 41 |
of cancer cells | 40 |
it was found | 40 |
with an adsorption | 40 |
metastatic breast cancer | 40 |
must be considered | 40 |
the availability of | 40 |
volume of distribution | 40 |
the side effects | 40 |
an adsorption energy | 40 |
can be seen | 40 |
in vitro antiviral | 40 |
use of these | 40 |
there were no | 40 |
van der waals | 40 |
hcq and cq | 40 |
in the community | 40 |
could be a | 40 |
the control of | 40 |
study showed that | 40 |
to the lungs | 40 |
interaction with the | 40 |
suggested that the | 40 |
should be avoided | 40 |
of breast cancer | 40 |
the clinical pharmacist | 40 |
the last years | 40 |
dose activated charcoal | 40 |
for cancer therapy | 40 |
in the pathogenesis | 40 |
clinical trials are | 40 |
than that of | 40 |
randomized clinical trial | 40 |
patients were included | 40 |
will be presented | 40 |
results suggest that | 39 |
of drugs that | 39 |
of the same | 39 |
of drug discovery | 39 |
revealed that the | 39 |
delivery of drugs | 39 |
it was observed | 39 |
the past years | 39 |
delivery to the | 39 |
factors such as | 39 |
allowed without permission | 39 |
a crucial role | 39 |
of cyp c | 39 |
in the clinic | 39 |
to describe the | 39 |
the authors declare | 39 |
considered to be | 39 |
study was conducted | 39 |
was found in | 39 |
in this work | 39 |
have been found | 39 |
in the drug | 39 |
respect to the | 39 |
the most promising | 39 |
for up to | 39 |
over the last | 39 |
these drugs are | 39 |
in the clinical | 39 |
no reuse allowed | 39 |
reuse allowed without | 39 |
also been reported | 39 |
the university of | 39 |
release of the | 39 |
rats treated with | 39 |
focused on the | 39 |
expression of the | 39 |
in animal models | 39 |
combination with other | 39 |
the drug was | 39 |
on the use | 39 |
with a high | 39 |
of in vitro | 39 |
hydroxychloroquine and chloroquine | 39 |
activity in the | 38 |
is due to | 38 |
to ensure that | 38 |
insights into the | 38 |
two or more | 38 |
by using the | 38 |
to be more | 38 |
patients infected with | 38 |
clinical characteristics of | 38 |
acute lung injury | 38 |
drugs that are | 38 |
the lymphatic system | 38 |
this drug is | 38 |
in the evaluation | 38 |
a dose of | 38 |
drug should be | 38 |
portion of the | 38 |
and management of | 38 |
is possible to | 38 |
of the skin | 38 |
should be administered | 38 |
in the present | 38 |
the last decade | 38 |
it was shown | 38 |
serve as a | 38 |
virtual screening of | 38 |
which is the | 38 |
as a treatment | 38 |
well as a | 38 |
advantage of the | 38 |
be considered in | 38 |
and toxic epidermal | 37 |
with the aim | 37 |
mouse model of | 37 |
were observed in | 37 |
new york city | 37 |
by the food | 37 |
it is the | 37 |
the adsorption energy | 37 |
for drug repositioning | 37 |
of the active | 37 |
of the four | 37 |
drug delivery in | 37 |
in the elderly | 37 |
mechanism of the | 37 |
similar to that | 37 |
there may be | 37 |
alone or in | 37 |
may be used | 37 |
of health and | 37 |
in the upper | 37 |
an average of | 37 |
in the h | 37 |
low molecular weight | 37 |
the occurrence of | 37 |
used as the | 37 |
kcal mol for | 37 |
the generation of | 37 |
characteristics of the | 37 |
of the body | 37 |
hyperplasia of the | 37 |
be noted that | 37 |
none of the | 37 |
small cell lung | 37 |
were obtained from | 37 |
the age of | 37 |
dependent on the | 37 |
was to evaluate | 37 |
is a common | 37 |
a function of | 37 |
in breast cancer | 36 |
that are not | 36 |
play a role | 36 |
was not peer | 36 |
its ability to | 36 |
components of the | 36 |
and use of | 36 |
of the m | 36 |
of drugs with | 36 |
as a model | 36 |
for the diagnosis | 36 |
for more than | 36 |
the metabolism of | 36 |
the pediatric population | 36 |
site of the | 36 |
has led to | 36 |
molecular dynamics simulation | 36 |
the interaction between | 36 |
was observed that | 36 |
in of cases | 36 |
of the respiratory | 36 |
nuclear magnetic resonance | 36 |
diffuse alveolar damage | 36 |
of a single | 36 |
the usefulness of | 36 |
the reduction of | 36 |
is required for | 36 |
and of the | 36 |
suggest that the | 36 |
inhibitors of sars | 36 |
drug delivery to | 36 |
part of a | 36 |
patients in the | 36 |
kcal mol with | 36 |
of the three | 36 |
research and development | 36 |
duration of the | 36 |
the goal of | 36 |
case of the | 36 |
to measure the | 35 |
can be a | 35 |
expressed in the | 35 |
total of patients | 35 |
in the process | 35 |
with a maximum | 35 |
taken into account | 35 |
during the first | 35 |
of drug repurposing | 35 |
the needs of | 35 |
that the drug | 35 |
to explore the | 35 |
and evaluation of | 35 |
of the world | 35 |
the contribution of | 35 |
proteins in the | 35 |
in silico pharmacology | 35 |
bind to the | 35 |
the emergency department | 35 |
play an important | 35 |
particularly in the | 35 |
to the use | 35 |
higher risk of | 35 |
resulted in the | 35 |
the choice of | 35 |
reported that the | 35 |
is involved in | 35 |
between the two | 35 |
in cancer therapy | 35 |
angiotensin converting enzyme | 35 |
is a key | 35 |
the implementation of | 35 |
performance of the | 35 |
consistent with the | 35 |
the start of | 35 |
with the highest | 35 |
attributed to the | 35 |
number of drugs | 34 |
is essential to | 34 |
a clinical pharmacist | 34 |
were associated with | 34 |
of antiviral drugs | 34 |
was performed using | 34 |
respiratory infectious diseases | 34 |
the preparation of | 34 |
in most cases | 34 |
the spread of | 34 |
it is worth | 34 |
for evaluation of | 34 |
risk factor for | 34 |
which have been | 34 |
interaction between the | 34 |
which in turn | 34 |
based virtual screening | 34 |
the lungs of | 34 |
should be noted | 34 |
of the covid | 34 |
of activated charcoal | 34 |
is mediated by | 34 |
for each drug | 34 |
action of the | 34 |
drugs can be | 34 |
of the new | 34 |
the mechanisms of | 34 |
not associated with | 34 |
is expected to | 34 |
many of these | 34 |
be effective against | 34 |
cancer cell lines | 34 |
in this section | 34 |
that may be | 34 |
affected by the | 34 |
was found that | 34 |
severity of the | 34 |
in pediatric patients | 34 |
a case of | 34 |
are based on | 34 |
the advantage of | 34 |
conditions such as | 34 |
the uptake of | 34 |
in the brain | 34 |
treatment of chronic | 34 |
hydroxychloroquine and azithromycin | 34 |
and has been | 34 |
binding of the | 34 |
has indicated that | 34 |
drugs that can | 33 |
has been widely | 33 |
to an increase | 33 |
was based on | 33 |
cases in which | 33 |
in comparison with | 33 |
in the plasma | 33 |
the increase in | 33 |
is required to | 33 |
interstitial lung disease | 33 |
the relevance of | 33 |
thought to be | 33 |
cyp a and | 33 |
of a protein | 33 |
yet to be | 33 |
both in vitro | 33 |
use of this | 33 |
sensitivity and specificity | 33 |
drug sales data | 33 |
in the hospital | 33 |
in rats and | 33 |
were found in | 33 |
the list of | 33 |
a broad spectrum | 33 |
treatment of acute | 33 |
in the tumor | 33 |
entry into the | 33 |
of the present | 33 |
results in a | 33 |
to be considered | 33 |
it is difficult | 33 |
have already been | 33 |
the results were | 33 |
who inject drugs | 33 |
the beginning of | 33 |
associated with an | 33 |
around the world | 33 |
patients with the | 33 |
of the current | 33 |
for delivery of | 33 |
in silico drug | 33 |
the sensitivity of | 33 |
health care system | 33 |
no conflict of | 33 |
of the binding | 33 |
our understanding of | 33 |
treated with the | 33 |
a new drug | 33 |
has been observed | 33 |
in hospitalized patients | 33 |
of action and | 33 |
of clinical pharmacy | 33 |
the efficiency of | 33 |
of the proposed | 33 |
in the world | 33 |
has been described | 33 |
identification of potential | 32 |
and the development | 32 |
of the major | 32 |
of these compounds | 32 |
of our study | 32 |
the existence of | 32 |
we aimed to | 32 |
for the identification | 32 |
from patients with | 32 |
a critical role | 32 |
the complexity of | 32 |
data were collected | 32 |
damage to the | 32 |
a clinical trial | 32 |
the drug delivery | 32 |
in new york | 32 |
the guidelines for | 32 |
control of the | 32 |
insight into the | 32 |
structure of sars | 32 |
of small molecules | 32 |
is used in | 32 |
cov and mers | 32 |
the most frequently | 32 |
the prediction of | 32 |
side effects and | 32 |
a novel coronavirus | 32 |
of the cell | 32 |
therapeutic efficacy of | 32 |
of the population | 32 |
of drugs in | 32 |
found to have | 32 |
but not in | 32 |
a consequence of | 32 |
has been associated | 32 |
be considered as | 32 |
to analyse the | 32 |
mg once a | 32 |
to overcome the | 32 |
comparison of the | 32 |
the general population | 32 |
drugs to the | 32 |
period of time | 32 |
may be required | 32 |
oral administration of | 32 |
antimicrobial drugs should | 32 |
of resistant bacteria | 32 |
focus on the | 32 |
there are two | 32 |
in patients who | 32 |
have been widely | 32 |
isolated from the | 32 |
into the cell | 32 |
human serum albumin | 32 |
involvement of the | 32 |
data from the | 31 |
the health of | 31 |
with the drug | 31 |
result in a | 31 |
in all cases | 31 |
most of these | 31 |
used in combination | 31 |
because it is | 31 |
in the control | 31 |
demonstrated that the | 31 |
for drug development | 31 |
syndrome and toxic | 31 |
also been shown | 31 |
with a new | 31 |
as a new | 31 |
state of the | 31 |
was not certified | 31 |
not certified by | 31 |
for the detection | 31 |
antimicrobial drug therapy | 31 |
its use in | 31 |
by peer review | 31 |
has been a | 31 |
further studies are | 31 |
was observed as | 31 |
for the drug | 31 |
to the target | 31 |
which could be | 31 |
results showed that | 31 |
to identify potential | 31 |
interfere with the | 31 |
available in the | 31 |
patients with acute | 31 |
over a period | 31 |
of anticancer drugs | 31 |
to address the | 31 |
of viral infections | 31 |
could also be | 31 |
in those with | 31 |
in the gastrointestinal | 31 |
interactions with the | 31 |
the accumulation of | 31 |
orders of magnitude | 31 |
is thought to | 31 |
is the author | 31 |
certified by peer | 31 |
prevention and control | 31 |
zika virus infection | 31 |
majority of the | 31 |
was to investigate | 31 |
for this reason | 31 |
a risk of | 31 |
a member of | 31 |
lesions in the | 31 |
was determined by | 31 |
and to the | 31 |
the levels of | 31 |
more than years | 31 |
hospitalized patients with | 31 |
the author funder | 31 |
been used as | 31 |
was shown that | 31 |
plays an important | 31 |
has recently been | 31 |
to make a | 31 |
contrast to the | 31 |
of the different | 31 |
binding site of | 31 |
the diagnosis and | 31 |
result of the | 31 |
carried out in | 31 |
as it is | 31 |
was performed in | 31 |
the lamina propria | 31 |
of adverse effects | 31 |
in the diagnosis | 31 |
be useful for | 31 |
relative to the | 31 |
the percentage of | 31 |
concentration of the | 31 |
the control group | 31 |
of up to | 31 |
in spite of | 31 |
studies on the | 31 |
of which are | 31 |
be effective in | 30 |
johnson syndrome and | 30 |
randomized controlled trial | 30 |
a key role | 30 |
to estimate the | 30 |
infectious diseases in | 30 |
expected to be | 30 |
as soon as | 30 |
chronic kidney disease | 30 |
and may be | 30 |
health and social | 30 |
any of the | 30 |
sars and mers | 30 |
the length of | 30 |
in another study | 30 |
linked to the | 30 |
in the cell | 30 |
in patients treated | 30 |
systematic review and | 30 |
significant difference in | 30 |
proved to be | 30 |
component of the | 30 |
in patients receiving | 30 |
mutations in the | 30 |
of adverse drug | 30 |
familial mediterranean fever | 30 |
the drug discovery | 30 |
findings suggest that | 30 |
was used in | 30 |
of the whole | 30 |
critical role in | 30 |
seen in the | 30 |
has shown that | 30 |
regions of the | 30 |
results indicate that | 30 |
can be observed | 30 |
and the drug | 30 |
is a potent | 30 |
occur in the | 30 |
basis of the | 30 |
accordance with the | 30 |
can result in | 30 |
to the same | 30 |
used as an | 30 |
was conducted in | 30 |
are in the | 30 |
it is an | 30 |
potent inhibitor of | 30 |
little or no | 30 |
withdrawal of the | 30 |
health care professionals | 30 |
of the various | 30 |
site of action | 30 |
american college of | 30 |
as a novel | 30 |
they are not | 30 |
better understanding of | 30 |
so that the | 30 |
difference in the | 30 |
view of the | 30 |
a medical device | 30 |
regulation of the | 30 |
on the pharmacokinetics | 30 |
cause of death | 30 |
c virus infection | 30 |
the lungs and | 30 |
liu et al | 30 |
and for the | 30 |
is similar to | 30 |
wang et al | 30 |
is needed to | 30 |
to the patient | 30 |
traditional chinese medicine | 30 |
the gastric mucosa | 30 |
reduction of the | 30 |
with the same | 30 |
in the usa | 29 |
discovery of new | 29 |
leads to the | 29 |
sustained release of | 29 |
for disease control | 29 |
mediated by the | 29 |
of the compounds | 29 |
have been studied | 29 |
has resulted in | 29 |
the spectrum of | 29 |
the accuracy of | 29 |
chen et al | 29 |
important in the | 29 |
active site of | 29 |
the scope of | 29 |
classified by the | 29 |
of the gastric | 29 |
in the design | 29 |
amino acid residues | 29 |
are characterized by | 29 |
for the study | 29 |
no significant difference | 29 |
binding to the | 29 |
and it has | 29 |
for this purpose | 29 |
this work was | 29 |
and the use | 29 |
a significant increase | 29 |
followed by the | 29 |
proven to be | 29 |
of causative microorganisms | 29 |
the need of | 29 |
the central nervous | 29 |
studies of the | 29 |
a retrospective study | 29 |
a lot of | 29 |
were the most | 29 |
be the most | 29 |
a drug delivery | 29 |
have been associated | 29 |
the cause of | 29 |
drug in the | 29 |
agents such as | 29 |
congenital heart disease | 29 |
is composed of | 29 |
course of the | 29 |
protein data bank | 29 |
are capable of | 29 |
in view of | 29 |
of a medical | 29 |
imaging findings of | 29 |
therapeutic options for | 29 |
in a large | 29 |
of the host | 29 |
according to their | 29 |
to compare the | 29 |
of the coronavirus | 29 |
has been the | 29 |
present study was | 29 |
to those of | 29 |
the patient and | 29 |
in a variety | 29 |
high doses of | 29 |
health care providers | 29 |
are present in | 29 |
the most effective | 29 |
features of the | 29 |
vitro antiviral activity | 29 |
may be the | 29 |
the entry of | 29 |
will also be | 29 |
and function of | 29 |
is the only | 29 |
we investigated the | 28 |
results from the | 28 |
have led to | 28 |
residues in the | 28 |
rats and mice | 28 |
show that the | 28 |
and discovery of | 28 |
a pilot study | 28 |
of health care | 28 |
of the pediatric | 28 |
discuss or describe | 28 |
but also to | 28 |
with at least | 28 |
to better understand | 28 |
most commonly used | 28 |
is classified by | 28 |
dna and rna | 28 |
respiratory tract infection | 28 |
to interact with | 28 |
with the development | 28 |
the public health | 28 |
management of respiratory | 28 |
shown in table | 28 |
the association between | 28 |
drug discovery process | 28 |
the integration of | 28 |
an anticancer drug | 28 |
were used for | 28 |
is widely used | 28 |
human cell lines | 28 |
seem to be | 28 |
will discuss or | 28 |
the first step | 28 |
to treat the | 28 |
of the test | 28 |
with more than | 28 |
li et al | 28 |
potential inhibitors of | 28 |
based on these | 28 |
commonly used in | 28 |
act as a | 28 |
of middle east | 28 |
in healthy volunteers | 28 |
are similar to | 28 |
the target cells | 28 |
a mixture of | 28 |
an increased risk | 28 |
of hydroxychloroquine in | 28 |
identification of the | 28 |
are used for | 28 |
to health care | 28 |
drug design and | 28 |
cancer cells and | 28 |
all of these | 28 |
in the mouse | 28 |
be applied to | 28 |
of this disease | 28 |
the probability of | 28 |
is dependent on | 28 |
studies are needed | 28 |
plasma protein binding | 28 |
significant increase in | 28 |
of lopinavir ritonavir | 28 |
the dose of | 28 |
approved for the | 28 |
the drugs are | 28 |
the safety and | 28 |
this is an | 28 |
are presented in | 28 |
in cancer cells | 28 |
there is also | 28 |
is a promising | 28 |
relationship between the | 28 |
would like to | 28 |
the chemical structure | 28 |
at our institution | 28 |
was approved by | 28 |
and the number | 28 |
clinical trials in | 28 |
results show that | 28 |
interact with the | 28 |
but it is | 28 |
on the market | 28 |
is a well | 28 |
of therapeutic agents | 28 |
as a function | 28 |
or absence of | 28 |
acts as a | 28 |
the understanding of | 28 |
a public health | 28 |
are listed in | 28 |
high level of | 28 |
resulting in the | 28 |
of the potential | 28 |
was reported in | 28 |
been linked to | 28 |
was the first | 28 |
well as to | 28 |
factors associated with | 27 |
and its derivatives | 27 |
in of patients | 27 |
aspects of the | 27 |
with rheumatoid arthritis | 27 |
clinical trials and | 27 |
is used for | 27 |
added to the | 27 |
or pharmaceutical that | 27 |
depend on the | 27 |
data on the | 27 |
number of the | 27 |
be included in | 27 |
data suggest that | 27 |
prediction of drug | 27 |
mg kg once | 27 |
one of these | 27 |
and the presence | 27 |
disease caused by | 27 |
a need for | 27 |
pharmaceutical that is | 27 |
can be applied | 27 |
and lack of | 27 |
review and meta | 27 |
device or pharmaceutical | 27 |
drug related problems | 27 |
that is classified | 27 |
of drugs to | 27 |
for in vivo | 27 |
of the oral | 27 |
with novel coronavirus | 27 |
of new drugs | 27 |
of hydroxychloroquine and | 27 |
as a promising | 27 |
investigational for intended | 27 |
medical device or | 27 |
retrospective review of | 27 |
to the high | 27 |
for biomedical applications | 27 |
remdesivir and chloroquine | 27 |
to deal with | 27 |
be a promising | 27 |
the outcome of | 27 |
estimated to be | 27 |
the amino acid | 27 |
for the discovery | 27 |
observed that the | 27 |
the liver and | 27 |
key role in | 27 |
in the regulation | 27 |
in the respiratory | 27 |
and systemic symptoms | 27 |
in drug development | 27 |
in a similar | 27 |
for targeted delivery | 27 |
studies have been | 27 |
the hypothesis that | 27 |
the future of | 27 |
for intended use | 27 |
of drug repositioning | 27 |
for the purpose | 27 |
two of the | 27 |
broad spectrum of | 27 |
all over the | 27 |
which there is | 27 |
were collected from | 27 |
iron oxide nanoparticles | 27 |
of natural products | 27 |
kcal mol and | 27 |
considered as a | 27 |
of the following | 27 |
the cyp c | 27 |
the focus of | 27 |
lower respiratory tract | 27 |
e g e | 27 |
as investigational for | 27 |
of this work | 27 |
retrospective cohort study | 27 |
limited number of | 27 |
could lead to | 27 |
effectively inhibit the | 27 |
and that the | 27 |
taking into account | 27 |
drug targets and | 27 |
the patients with | 27 |
in the course | 27 |
to prevent the | 27 |
a use of | 27 |
it would be | 27 |
in the educational | 27 |
were carried out | 27 |
controlled drug delivery | 27 |
the educational content | 27 |
this is not | 27 |
virtual screening and | 27 |
in the second | 27 |
with other drugs | 27 |
delivery of the | 27 |
respiratory tract infections | 27 |
in the uk | 26 |
for the covid | 26 |
drugs used in | 26 |
do not have | 26 |
with eosinophilia and | 26 |
as a possible | 26 |
vascular endothelial growth | 26 |
treatments for covid | 26 |
a new coronavirus | 26 |
early stages of | 26 |
only a few | 26 |
of in silico | 26 |
mean age of | 26 |
clinical features of | 26 |
united states food | 26 |
determined by the | 26 |
idiopathic pulmonary fibrosis | 26 |
cq and hcq | 26 |
is the case | 26 |
and side effects | 26 |
in lung cancer | 26 |
therapy should be | 26 |
as compared with | 26 |
will be used | 26 |
the recently emerged | 26 |
the gi tract | 26 |
listed in table | 26 |
due to an | 26 |
identification of a | 26 |
applied to the | 26 |
x for peer | 26 |
delivery systems for | 26 |
the adverse effects | 26 |
the severe acute | 26 |
study reported that | 26 |
characterized by a | 26 |
the advent of | 26 |
and it was | 26 |
was reported to | 26 |
duration of treatment | 26 |
recently emerged novel | 26 |
such as a | 26 |
did not have | 26 |
and should be | 26 |
exposure to the | 26 |
in rats treated | 26 |
pneumonia in wuhan | 26 |
chloroquine effectively inhibit | 26 |
as they are | 26 |
indicate that the | 26 |
fold higher than | 26 |
the oral cavity | 26 |
of the enzyme | 26 |
the target site | 26 |
of the effects | 26 |
belonging to the | 26 |
authors declare no | 26 |
innate immune response | 26 |
upper respiratory tract | 26 |
was to assess | 26 |
there are also | 26 |
in these patients | 26 |
the results obtained | 26 |
higher than that | 26 |
the determination of | 26 |
disruption of the | 26 |
be responsible for | 26 |
in elderly patients | 26 |
marine natural products | 26 |
for peer review | 26 |
the drug release | 26 |
various types of | 26 |
the drug to | 26 |
and duration of | 26 |
and on the | 26 |
to note that | 26 |
which leads to | 26 |
of this approach | 26 |
and the other | 26 |
been reported that | 26 |
results in the | 26 |
stages of the | 26 |
eosinophilia and systemic | 26 |
inhibit the recently | 26 |
are used in | 26 |
cd t cells | 26 |
model of the | 26 |
in clinical studies | 26 |
of the above | 26 |
of patients in | 26 |
than of the | 26 |
the period of | 26 |
effects of drugs | 26 |
peer review of | 26 |
it was also | 26 |
a drug that | 26 |
patients who are | 26 |
this article is | 26 |
in this way | 26 |
in line with | 26 |
for many years | 26 |
of patients were | 26 |
endothelial growth factor | 26 |
of the leading | 26 |
group of patients | 26 |
order to improve | 26 |
acute and chronic | 26 |
they do not | 26 |
this approach is | 25 |
was also observed | 25 |
been carried out | 25 |
patients who have | 25 |
drugs to treat | 25 |
characterized by the | 25 |
chemical structure of | 25 |
up to days | 25 |
safe and effective | 25 |
a better understanding | 25 |
that there are | 25 |
to ensure the | 25 |
states food and | 25 |
immune response to | 25 |
refer to the | 25 |
along with a | 25 |
the association of | 25 |
remains to be | 25 |
significantly associated with | 25 |
in the skin | 25 |
to be involved | 25 |
little is known | 25 |
was performed by | 25 |
leading cause of | 25 |
the human interactome | 25 |
intravenous injection or | 25 |
in which there | 25 |
are expected to | 25 |
approach to the | 25 |
a potent inhibitor | 25 |
are summarized in | 25 |
is important for | 25 |
for at least | 25 |
drug repositioning for | 25 |
the cell surface | 25 |
in this area | 25 |
in hepatocellular carcinoma | 25 |
the excess proton | 25 |
have suggested that | 25 |
the binding pocket | 25 |
are necessary to | 25 |
people who inject | 25 |
correlated with the | 25 |
structure of a | 25 |
novel coronavirus in | 25 |
controlled drug release | 25 |
method for the | 25 |
the strength of | 25 |
drugs that have | 25 |
were identified in | 25 |
they are also | 25 |
is a very | 25 |
carried out by | 25 |
development of an | 25 |
has been studied | 25 |
gene expression in | 25 |
emerged novel coronavirus | 25 |
molecular dynamics simulations | 25 |
and in some | 25 |
and there is | 25 |
molecular mechanisms of | 25 |
access to health | 25 |
and pharmacokinetics of | 25 |
the rest of | 25 |
transforming growth factor | 25 |
a retrospective review | 25 |
which results in | 25 |
were identified as | 25 |
into account the | 25 |
crucial role in | 25 |
a subset of | 25 |
appearance of the | 25 |
and chloroquine effectively | 25 |
e mg kg | 25 |
of human immunodeficiency | 25 |
drug development and | 25 |
may have a | 25 |
to identify and | 25 |
injection or drip | 25 |
and mechanism of | 25 |
employed in the | 25 |
acquired pneumonia in | 25 |
and clinical trials | 25 |
management of covid | 25 |
in the next | 25 |
modification of the | 25 |
treatment for covid | 25 |
drug release in | 25 |
in silico screening | 25 |
a spectrum of | 25 |
may contribute to | 25 |
at risk of | 25 |
a single dose | 25 |
in both the | 25 |
fold increase in | 25 |
be explained by | 25 |
as an effective | 25 |
increase the risk | 25 |
its role in | 25 |
the cell membrane | 25 |
level of the | 25 |
for a particular | 25 |
is still a | 25 |
examination of the | 25 |
are caused by | 25 |
presence or absence | 25 |
during the study | 25 |
no significant differences | 25 |
a change in | 25 |
as an anti | 25 |
at least in | 25 |
to quantify the | 25 |
the health care | 25 |
taken up by | 25 |
although it is | 25 |
even in the | 25 |
the vast majority | 25 |
shows that the | 25 |
disease control and | 25 |
the area of | 25 |
the patients were | 25 |
and review of | 25 |
are related to | 25 |
a diagnosis of | 25 |
region of the | 24 |
the incorporation of | 24 |
of these two | 24 |
ill patients with | 24 |
controlled release of | 24 |
of the novel | 24 |
options for the | 24 |
on the development | 24 |
are composed of | 24 |
of the therapeutic | 24 |
of a large | 24 |
plasma concentrations of | 24 |
in the late | 24 |
the development and | 24 |
to establish a | 24 |
has been approved | 24 |
be attributed to | 24 |
strategy for the | 24 |
acute renal failure | 24 |
example of a | 24 |
kg once a | 24 |
acute generalized exanthematous | 24 |
of the data | 24 |
in cystic fibrosis | 24 |
suggests that the | 24 |
viral replication and | 24 |
objective was to | 24 |
high concentrations of | 24 |
rest of the | 24 |
administration of a | 24 |
in a dose | 24 |
can be considered | 24 |
a basis for | 24 |
safety of the | 24 |
the skin and | 24 |
may be more | 24 |
patients with renal | 24 |
the therapy of | 24 |
patients in whom | 24 |
the patient is | 24 |
is known about | 24 |
of the mucosa | 24 |
to minimize the | 24 |
b and c | 24 |
to our knowledge | 24 |
are essential for | 24 |
for the use | 24 |
of the use | 24 |
emergency use authorization | 24 |
were subjected to | 24 |
therapeutic drug monitoring | 24 |
be carried out | 24 |
the binding affinity | 24 |
of patients who | 24 |
no evidence of | 24 |
bovine serum albumin | 24 |
pi k akt | 24 |
the history of | 24 |
over the world | 24 |
to test the | 24 |
japanese respiratory society | 24 |
is found in | 24 |
inhibitor of the | 24 |
the properties of | 24 |
of at least | 24 |
will focus on | 24 |
quality of the | 24 |
against the sars | 24 |
and at the | 24 |
a model of | 24 |
the host cells | 24 |
after administration of | 24 |
who use drugs | 24 |
in the area | 24 |
in diseased tissues | 24 |
significant reduction in | 24 |
drug repurposing is | 24 |
effect of colchicine | 24 |
in rheumatoid arthritis | 24 |
than half of | 24 |
with an average | 24 |
the benefit of | 24 |
application of the | 24 |
higher than in | 24 |
defined as the | 24 |
bound to the | 24 |
us food and | 24 |
it is likely | 24 |
levels of the | 24 |
up to of | 24 |
this version posted | 24 |
by inhibiting the | 24 |
at the site | 24 |
the crystal structure | 24 |
the nasal cavity | 24 |
cells in vitro | 24 |
also be considered | 24 |
and could be | 24 |
is not clear | 24 |
was applied to | 24 |
as an example | 24 |
between the drug | 24 |
for the design | 24 |
value of the | 24 |
no effect on | 24 |
of the antiviral | 24 |
control and prevention | 24 |
associated pneumonia in | 24 |
owing to the | 24 |
patients with rheumatoid | 24 |
broad range of | 24 |
at a dose | 24 |
in critically ill | 24 |
of respiratory infectious | 24 |
in the lower | 24 |
infections caused by | 24 |
people who use | 23 |
increases the risk | 23 |
by the use | 23 |
in a single | 23 |
of ebola virus | 23 |
concentrations of the | 23 |
be taken into | 23 |
was supported by | 23 |
been described in | 23 |
overview of the | 23 |
identified in the | 23 |
inhibitory effect of | 23 |
of antiviral agents | 23 |
the innate immune | 23 |
been approved for | 23 |
as low as | 23 |
identified as a | 23 |
the difference in | 23 |
the drug development | 23 |
the interactions between | 23 |
resistance to the | 23 |
the past decade | 23 |
and frequency of | 23 |
in this population | 23 |
in human plasma | 23 |
to the discovery | 23 |
the disease and | 23 |
can serve as | 23 |
discovery of novel | 23 |
by the same | 23 |
distribution of the | 23 |
in the use | 23 |
de novo drug | 23 |
a matter of | 23 |
each of these | 23 |
in the binding | 23 |
and adverse effects | 23 |
did not show | 23 |
knowledge graph completion | 23 |
a potential drug | 23 |
huang et al | 23 |
about of the | 23 |
the respiratory system | 23 |
of drug development | 23 |
of cyp d | 23 |
the evolution of | 23 |
we used the | 23 |
of the complex | 23 |
proteins such as | 23 |
other types of | 23 |
to bind to | 23 |
walled carbon nanotubes | 23 |
cov and sars | 23 |
strength of the | 23 |
by the pharmacist | 23 |
that they are | 23 |
as drug delivery | 23 |
as one of | 23 |
the advantages of | 23 |
the most abundant | 23 |
to review the | 23 |
in the prevention | 23 |
structures of the | 23 |
of treatment with | 23 |
be a potential | 23 |
which is an | 23 |
into the host | 23 |
the human protein | 23 |
as a prophylactic | 23 |
for the patient | 23 |
is a need | 23 |
is known as | 23 |
the virus to | 23 |
may be useful | 23 |
the japanese respiratory | 23 |
molecular weight and | 23 |
and have been | 23 |
among the most | 23 |
binding affinity of | 23 |
of colchicine in | 23 |
only of the | 23 |
it possible to | 23 |
close to the | 23 |
produced by the | 23 |
effects of a | 23 |
leads to a | 23 |
in the near | 23 |
in severe cases | 23 |
ongoing clinical trials | 23 |
available on the | 23 |
angiotensin receptor blockers | 23 |
basis for the | 23 |
the sum of | 23 |
high risk of | 23 |
of them were | 23 |
methods for the | 23 |
the near future | 23 |
is considered to | 23 |
treatment of hiv | 23 |
protein of sars | 23 |
is effective in | 23 |
in most of | 23 |
effectiveness of the | 23 |
the loss of | 23 |
the response to | 23 |
been studied in | 23 |
and is a | 23 |
is necessary for | 23 |
phase ii trial | 23 |
an evaluation of | 23 |
treatment of lung | 23 |
for the patients | 23 |
intensive care units | 23 |
have been published | 23 |
consists of a | 23 |
of potential drugs | 22 |
exhibit is to | 22 |
the ratio of | 22 |
to support the | 22 |
infection in vitro | 22 |
two types of | 22 |
only in the | 22 |
oral drug delivery | 22 |
it will be | 22 |
the toxicity of | 22 |
the most recent | 22 |
of amino acids | 22 |
of these agents | 22 |
elimination of the | 22 |
a model for | 22 |
the viral replication | 22 |
challenges and recommendations | 22 |
a author funder | 22 |
was defined as | 22 |
it is made | 22 |
of the offending | 22 |
in vivo in | 22 |
for oral delivery | 22 |
that in the | 22 |
when there is | 22 |
as opposed to | 22 |
most of them | 22 |
used to determine | 22 |
of fda approved | 22 |
been proposed to | 22 |
when they are | 22 |
m proton channel | 22 |
of the national | 22 |
point of view | 22 |
replication of sars | 22 |
summarized in table | 22 |
analysis was performed | 22 |
an underlying disease | 22 |
the opportunity to | 22 |
an in silico | 22 |
symptoms such as | 22 |
they may be | 22 |
carcinoma of the | 22 |
to the other | 22 |
we aim to | 22 |
of laboratory animals | 22 |
a method for | 22 |
patients with pneumonia | 22 |
can be easily | 22 |
in man and | 22 |
in the heart | 22 |
on the efficacy | 22 |
a role for | 22 |
generalized exanthematous pustulosis | 22 |
relation to the | 22 |
indicated that the | 22 |
in a more | 22 |
during the course | 22 |
been demonstrated in | 22 |
the systemic circulation | 22 |
conditions of the | 22 |
has become a | 22 |
to validate the | 22 |
to the cell | 22 |
interactions between the | 22 |
primary health care | 22 |
because they are | 22 |
development of novel | 22 |
the current study | 22 |
signs and symptoms | 22 |
novel coronavirus from | 22 |
the state of | 22 |
drug has been | 22 |
the changes in | 22 |
with coronavirus disease | 22 |
take advantage of | 22 |
were identified and | 22 |
for novel coronavirus | 22 |
a few days | 22 |
a class of | 22 |
the affinity of | 22 |
rapid identification of | 22 |
essential for the | 22 |
in the gastric | 22 |
for in silico | 22 |
the human genome | 22 |
been approved by | 22 |
methods have been | 22 |
a day or | 22 |
results of an | 22 |
in health care | 22 |
should be conducted | 22 |
the transmission of | 22 |
of the heart | 22 |
a phase i | 22 |
reported to have | 22 |
red blood cells | 22 |
it has a | 22 |
the treatment and | 22 |
the cleavage of | 22 |
france please specify | 22 |
combined with other | 22 |
antiviral activity and | 22 |
a cause of | 22 |
drugs with a | 22 |
age of years | 22 |
the ns a | 22 |
potential to be | 22 |
in more than | 22 |
of the high | 22 |
to be able | 22 |
was no significant | 22 |
is in the | 22 |
in the active | 22 |
to control the | 22 |
to the lung | 22 |
of drug candidates | 22 |
to play a | 22 |
treatment in the | 22 |
was performed to | 22 |
if there is | 22 |
venom of the | 22 |
with a history | 22 |
of medication reconciliation | 22 |
is to be | 22 |
the risk for | 22 |
the problem of | 22 |
a retrospective cohort | 22 |
the drugs and | 22 |
leading to a | 22 |
reduce the risk | 22 |
based drug repurposing | 22 |
of the receptor | 22 |
is a useful | 22 |
more than half | 21 |
required for the | 21 |
these findings suggest | 21 |
breast cancer patients | 21 |
novel coronavirus pneumonia | 21 |
drug repurposing and | 21 |
evolution of the | 21 |
the time and | 21 |
used in a | 21 |
to the treatment | 21 |
treatment of respiratory | 21 |
pharmacokinetics and pharmacodynamics | 21 |
cells treated with | 21 |
are important for | 21 |
to generate a | 21 |
drugs and vaccines | 21 |
adults and children | 21 |
been developed to | 21 |
made available under | 21 |
rapid development of | 21 |
a major role | 21 |
of exposure to | 21 |
be useful to | 21 |
formation of the | 21 |
with each other | 21 |
used to assess | 21 |
one of them | 21 |
under a author | 21 |
that they have | 21 |
if they are | 21 |
maximum adsorption energy | 21 |
of the infection | 21 |
use of drugs | 21 |
the costs of | 21 |
at room temperature | 21 |
results of this | 21 |
as long as | 21 |
the coronavirus disease | 21 |
treatment of coronavirus | 21 |
available under a | 21 |
proteins involved in | 21 |
treatment of influenza | 21 |
after treatment with | 21 |
but also the | 21 |
of the primary | 21 |
hydrogen bonds with | 21 |
is to provide | 21 |
human african trypanosomiasis | 21 |
in which a | 21 |
of which is | 21 |
is the main | 21 |
have been approved | 21 |
the sars coronavirus | 21 |
at least two | 21 |
pediatric patients with | 21 |
we used a | 21 |
polymorphisms in the | 21 |
and type of | 21 |
in the water | 21 |
is a risk | 21 |
use of antibiotics | 21 |
drugs on the | 21 |
of the c | 21 |
activated charcoal in | 21 |
been shown in | 21 |
the results showed | 21 |
drug use and | 21 |
a cohort of | 21 |
should be combined | 21 |
to decrease the | 21 |
a first choices | 21 |
an animal model | 21 |
of patients infected | 21 |
effectiveness and safety | 21 |
not only to | 21 |
the characterization of | 21 |
may be due | 21 |
prediction of the | 21 |
at this point | 21 |
vast majority of | 21 |
types of cancer | 21 |
of this review | 21 |
for the assessment | 21 |
international license it | 21 |
the community pharmacy | 21 |
poster sessions v | 21 |
that there was | 21 |
and the results | 21 |
occurs in the | 21 |
drug for the | 21 |
national institute of | 21 |
in vitro activity | 21 |
due to covid | 21 |
of the stomach | 21 |
be a useful | 21 |
clinical trials of | 21 |
included in this | 21 |
vero e cells | 21 |
of chloroquine hydroxychloroquine | 21 |
patients suffering from | 21 |
of sjs ten | 21 |
to obtain a | 21 |
the point of | 21 |
is consistent with | 21 |
interest in the | 21 |
be seen in | 21 |
significant differences in | 21 |
less likely to | 21 |
for each of | 21 |
in health and | 21 |
in all patients | 21 |
molecular docking study | 21 |
are available for | 21 |
of nucleic acids | 21 |
of carbon nanotubes | 21 |
phase i clinical | 21 |
an understanding of | 21 |
more common in | 21 |
has been an | 21 |
were shown to | 21 |
it is essential | 21 |
at the level | 21 |
profile of the | 21 |
of severe covid | 21 |
treatment with the | 21 |
with a mean | 21 |
mozafari et al | 21 |
to elucidate the | 21 |
images of the | 21 |
induced by the | 21 |
of the initial | 21 |
a broad range | 21 |
in the production | 21 |
zhang et al | 21 |
effective treatment of | 21 |
clinical trial of | 21 |
in the region | 21 |
for a drug | 21 |
is the major | 21 |
and lead to | 21 |
and other drugs | 21 |
energy gap by | 21 |
is made available | 21 |
an immune response | 21 |
and in silico | 21 |
area under the | 21 |
been demonstrated to | 21 |
residues of the | 21 |
those who are | 21 |
it is noteworthy | 21 |
of cases of | 21 |
led to an | 21 |
in human cell | 21 |
of the gastrointestinal | 21 |
on the drug | 21 |
we observed that | 21 |
virus infection in | 21 |
determination of the | 21 |
approach for the | 21 |
activity against sars | 21 |
binds to the | 21 |
living with hiv | 21 |
to respond to | 21 |
the decrease in | 21 |
believed to be | 21 |
the mortality rate | 21 |
of hepatocellular carcinoma | 21 |
ranging from to | 21 |
d structure of | 21 |
the work of | 21 |
to the presence | 21 |
in vivo evaluation | 21 |
and hepatitis c | 21 |
give rise to | 21 |
with a decrease | 21 |
hospitalized with severe | 21 |
pulmonary delivery of | 21 |
diseases in children | 21 |
a decrease of | 21 |
the mean age | 21 |
effective in the | 21 |
in vitro model | 21 |
the in silico | 21 |
zhou et al | 21 |
that should be | 21 |
at the target | 21 |
drug repurposing approach | 21 |
to define the | 21 |
the patient with | 21 |
and health care | 21 |
areas of the | 21 |
of the cyp | 21 |
license it is | 21 |
of antimicrobial drug | 20 |
molecules in the | 20 |
widely used to | 20 |
the training set | 20 |
of new drug | 20 |
the developing world | 20 |
our results suggest | 20 |
to establish the | 20 |
in collaboration with | 20 |
often associated with | 20 |
in the initial | 20 |
been applied to | 20 |
for coronavirus disease | 20 |
drugs for treatment | 20 |
oxidative stress and | 20 |
to address this | 20 |
to the lack | 20 |
a focus on | 20 |
preclinical and clinical | 20 |
patients who were | 20 |
antiviral effects of | 20 |
infected with sars | 20 |
response of the | 20 |
based on our | 20 |
of dress dihs | 20 |
have been made | 20 |
management of the | 20 |
studies have demonstrated | 20 |
of the structure | 20 |
the energy gap | 20 |
to determine if | 20 |
the anticancer drug | 20 |